Orbimed Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
107
Total Value
4035711615
Accession Number
0001172661-25-002355
Form Type
13F-HR
Manager Name
Orbimed Advisors LLC
Data Enrichment
92% identified
98 identified9 unidentified

Holdings

107 positions
Manager:
Search and click to pin securities to the top
Adicet Bio, Inc.
Shares:
11447140(+0.0%)
Value:
$8.6B(-21.5%)
ADC Therapeutics SA
Shares:
5968451(+0.0%)
Value:
$8.4B(-29.1%)
Prelude Therapeutics Inc
Shares:
10909256(+0.0%)
Value:
$8.4B(-39.8%)
78464A870
Shares:
100000(-73.1%)
Value:
$8.1B(-75.8%)
Avalo Therapeutics, Inc.
Shares:
967000(+0.0%)
Value:
$7.7B(+7.8%)
SpringWorks Therapeutics, Inc.
Shares:
172600(-86.2%)
Value:
$7.6B(-83.2%)
Whitehawk Therapeutics, Inc.
Shares:
4166000
Value:
$7.4B
Akero Therapeutics, Inc.
Shares:
179900(+172.6%)
Value:
$7.3B(+296.6%)
PMV Pharmaceuticals, Inc.
Shares:
6475291(+0.0%)
Value:
$7.1B(-27.8%)
Trevi Therapeutics, Inc.
Shares:
1120000
Value:
$7.0B
G52441105
Shares:
250000
Value:
$6.2B
Corbus Pharmaceuticals Holdings, Inc.
Shares:
1172287(+0.0%)
Value:
$6.2B(-55.0%)
45779A846
Shares:
2133405(+0.0%)
Value:
$5.7B(+2.3%)
Scholar Rock Holding Corp
Shares:
151800(+0.0%)
Value:
$4.9B(-25.6%)
Forte Biosciences, Inc.
Shares:
593088(-1.1%)
Value:
$4.6B(-66.2%)
Ikena Oncology, Inc.
Shares:
3539358(+0.0%)
Value:
$4.5B(-21.9%)
000000000
Shares:
5680186(+0.0%)
Value:
$4.4B(-39.8%)
Krystal Biotech, Inc.
Shares:
23500(+0.0%)
Value:
$4.2B(+15.1%)
29286M105
Shares:
891616(-3.1%)
Value:
$4.0B(-34.7%)
Oric Pharmaceuticals, Inc.
Shares:
700000
Value:
$3.9B